Huiping Zhang, PhD

Associate Professor, Psychiatry

Huiping Zhang
617.358.3689
72 East Concord Street

Biography

Huiping Zhang, PhD, is an Associate Professor of Psychiatry at the Boston University School of Medicine. He has a long history with the Yale University School of Medicine, where he completed his postdoc training and then served as a Research Associate Scientist (equivalent to Research Assistant Professor), Assistant Professor (tenure-track), and Research Scientist (equivalent to Research Associate Professor) before coming to Boston University. He is an editorial board member of academic journals such as the Journal of Addiction Research & Therapy, the Journal of Depression & Anxiety, and PLOS One. His research focused on genetic and epigenetic studies of substance use disorders (SUDs) and related psychiatric disorders and traits. He is currently the PI of two research grants (R01 and R21) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and one research grant from the Boston University Clinical Translational Science Institute (CTSI). Additionally, he is the subcontract PI of a R01 from the National Institute of Child Health and Human Development (NICHD).

Other Positions

  • Associate Professor, Biomedical Genetics, Medicine, Boston University School of Medicine
  • Member, Genome Science Institute, Boston University
  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences

Education

  • Queen's University, PhD
  • Tongji Medical University, MS
  • Central China Normal University, BS

Publications

  • Published on 5/27/2022

    Liu Y, Zhang H. RNA m6A Modification Changes in Postmortem Nucleus Accumbens of Subjects with Alcohol Use Disorder: A Pilot Study. Genes (Basel). 2022 May 27; 13(6). PMID: 35741720.

    Read at: PubMed
  • Published on 5/17/2022

    Borrelli KN, Wachman EM, Beierle JA, Taglauer ES, Jain M, Bryant CD, Zhang H. Effect of Prenatal Opioid Exposure on the Human Placental Methylome. Biomedicines. 2022 May 17; 10(5). PMID: 35625888.

    Read at: PubMed
  • Published on 10/2/2021

    Lim Y, Beane-Ebel JE, Tanaka Y, Ning B, Husted CR, Henderson DC, Xiang Y, Park IH, Farrer LA, Zhang H. Exploration of alcohol use disorder-associated brain miRNA-mRNA regulatory networks. Transl Psychiatry. 2021 10 02; 11(1):504. PMID: 34601489.

    Read at: PubMed
  • Published on 11/17/2020

    Moazzam M, Yim T, Kumaresan V, Henderson DC, Farrer LA, Zhang H. Analysis of telomere length variation and Shelterin complex subunit gene expression changes in ethanol-exposed human embryonic stem cells. J Psychiatr Res. 2021 11; 143:543-549. PMID: 33243459.

    Read at: PubMed
  • Published on 6/29/2020

    Wachman EM, Wang A, Isley BC, Boateng J, Beierle JA, Hansbury A, Shrestha H, Bryant C, Zhang H. Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study. Explor Med. 2020 Jun; 1(3):124-135. PMID: 33763662.

    Read at: PubMed
  • Published on 6/4/2020

    Lin H, Wang F, Rosato AJ, Farrer LA, Henderson DC, Zhang H. Prefrontal cortex eQTLs/mQTLs enriched in genetic variants associated with alcohol use disorder and other diseases. Epigenomics. 2020 05; 12(9):789-800. PMID: 32496132.

    Read at: PubMed
  • Published on 3/13/2020

    Dai Y, Hu R, Pei G, Zhang H, Zhao Z, Jia P. Diverse types of genomic evidence converge on alcohol use disorder risk genes. J Med Genet. 2020 11; 57(11):733-743. PMID: 32170004.

    Read at: PubMed
  • Published on 2/7/2020

    Lin Y, Kranzler HR, Farrer LA, Xu H, Henderson DC, Zhang H. An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence. Pharmacogenomics J. 2020 10; 20(5):672-680. PMID: 32029903.

    Read at: PubMed
  • Published on 11/30/2019

    Fu Y, Zhou N, Yu Y, Zhang H, Sun Y, Zhang M, Chen X, Wang Y, Yu Q. Profiling of schizophrenia-associated serum peptides by MALDI-TOF-MS. J Neural Transm (Vienna). 2020 01; 127(1):95-101. PMID: 31786691.

    Read at: PubMed
  • Published on 7/18/2019

    Yang M, Zhou N, Zhang H, Kang G, Cao B, Kang Q, Li R, Zhu X, Rao W, Yu Q. Kininogen-1 as a protein biomarker for schizophrenia through mass spectrometry and genetic association analyses. PeerJ. 2019; 7:e7327. PMID: 31346501.

    Read at: PubMed

View 64 more publications: View full profile at BUMC

View all profiles